Vivus, Inc. has recalled 4,240 bottles of PANCREAZE (pancrelipase) Delayed-Release Capsules because the medication failed to meet stability specifications. PANCREAZE is a prescription medication used to help the body digest food when the pancreas does not produce enough enzymes. This recall involves 100-count bottles from a single production lot, and consumers who use this medication should contact their healthcare provider to discuss their treatment.
The failure to meet stability specifications means the medication may lose its potency or performance before its expiration date. This could result in the drug being less effective at helping the body break down and absorb nutrients from food.
You have 2 options:
Manufactured by VIVUS LLC, Campbell, CA 95008.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.